Reports link Dupixent to T-cell lymphomas; see eligibility and evidence Why Lawsuits Are Being Filed Patients across the U.S. are filing lawsuits alleging that Dupixent® (dupilumab)—prescribed for eczema, asthma, nasal polyps, and other conditions—may trigger, worsen, or mask a cancer of the immune system called cutaneous T-cell lymphoma (CTCL). Core claims focus on whether the…
Read more
Dozens of lawsuits are being filed across the United States against hair relaxer manufacturers alleging that Black women are being targeted with aggressive advertisements that encourage the use of chemical hair straighteners, without disclosing the risk of breast cancer, endometrial cancer, uterine cancer and other life-altering injuries. Science Has Long Revealed Link Between Hair Relaxers…
Read more
The Issue High concentrations of toxic chemical solvents were discovered in Camp Lejeune’s drinking water, This information, however, was not disclosed to the public until two decades after it was discovered The chemicals involved are known to cause birth defects as well as a multitude of medical conditions including – Bladder cancer Leukemia Kidney cancer…
Read more
The findings of a new study highlight the consequences which may result from a delayed cancer diagnosis, indicating even a one month failure to detect cancer could be the difference between life and death for some patients. In a study published earlier this month in the medical journal The BMJ, Canadian researchers indicate even a…
Read more
The findings of a new study appear to confirm that surgical breast implant removal is the best way to treat a rare type of cancer linked to the design of certain recalled products with a textured surface. Last year, Allergan was forced to issue worldwide breast implant recalls which impacted its entire line of “Biocell” macrotextured…
Read more
